Back to search

Denmark· DK-28106559020

Icatibant "GP Pharm"

A icatibant product containing icatibantacetat, registered in Denmark by GP-Pharm S.A.. The same ATC class is registered in 15 of our 19 countries.

ATC B06AC02

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedIcatibant "GP Pharm"ATCB06AC02REGISTER NO.DK-28106559020PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Icatibant is registered in 15 of 19 countries.

Countries holding a registration under ATC B06AC02 (icatibant), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 8 of them publish a price we can compare per daily dose

Icatibant · ATC B06AC02

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Icatibantacetat
Manufacturer
GP-Pharm S.A.
Country
Denmark (DK)
ATC code
B06AC02
ATC class
Icatibant
Defined daily dose
30 mg, P
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28106559020

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

10 interactions on record for icatibant.

Graded by severity as the source publishes them — 10 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Icatibant · interactions on record

10 records

  • 10 moderate

Most severe, free to view

  • CaptoprilC09AA01moderate
  • EnalaprilC09AA02moderate
  • LisinoprilC09AA03moderate
  • PerindoprilC09AA04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/23582282-7935-4fc0-b597-83b704ad5368
GET /v1/drugs/23582282-7935-4fc0-b597-83b704ad5368?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "injektionsvæske, opløsning i fyldt injektionssprøjte",
  "source": "dkma",
  "strength": "30 mg",
  "auth_role": "RMS",
  "dk_drugid": "28106559020",
  "substance": "Icatibantacetat",
  "auth_procedure": "Decentral procedure",
  "in_medicinpriser": false,
  "registration_date_serial": "44684"
}

See everything about icatibant.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.